LRRN4CL and uveal melanoma: The TCGA database shows there is a range of LRRN4CL mRNA expression levels across 32 cancer types; expression is enriched in melanomas, with cutaneous melanoma and uveal melanoma showing the highest levels (Fig. 5a).